Bio
Dr. Dana Leach, Vice President of Preclinical Development and Immunopharmacology at Pharmexa.
Associated papers
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Dr. Dana Leach, Vice President of Preclinical Development and Immunopharmacology at Pharmexa.